Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study
<p>Abstract</p> <p>Background</p> <p>We have previously demonstrated that high tumor tissue levels of TIMP-1 are associated with no or limited clinical benefit from chemotherapy with CMF and anthracyclines in metastatic breast cancer patients. Here, we extend our invest...
Main Authors: | Foekens John A, Meijer-van Gelder Marion E, Look Maxime P, Schrohl Anne-Sofie, Brünner Nils |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/322 |
Similar Items
-
Expression of tissue inhibitors of metalloproteinase 1 (TIMP-1) in gastric cancer tissue.
by: Andrzej Kemona, et al.
Published: (2010-02-01) -
Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) als prometastatischer Faktor
by: Halbgewachs, Birgit
Published: (2010) -
The immunolocalization of the metalloproteinases and their inhibitor, TIMP, in cells and tissues
by: Hembry, Rosalind Marian
Published: (1991) -
Immunohistochemical Expression of Tissue Inhibitor of Metalloproteinase-1 (Timp-1) in Invasive Breast Carcinoma
by: Suada Kuskunović, et al.
Published: (2009-05-01) -
Studies on the structure and function of tissue inhibitor of metalloproteinases (TIMP)
by: Williamson, Richard A.
Published: (1990)